(Press-News.org) Boston, MA – Today, the Kraft Center for Community Health at Mass General Brigham announced that the winner of the inaugural Kraft Prize for Excellence and Innovation in Community Health is ThriveLink, a telephonic AI enrollment solution that empowers families to verbally complete and submit applications for safety-net programs like health insurance, food stamps and utility assistance. The St. Louis-based organization was selected for the $100,000 national prize from nearly 150 applications submitted from across the country, all of which were dedicated to the idea of making a transformative or innovative impact on health outcomes in their communities.
In addition to ThriveLink being selected as the winner of the Kraft Prize, two organizations were selected as finalists: Mae, a digital health platform working to improve maternal health outcomes and Sober Sidekick, a peer-led application that aims to decrease the rate of relapses among individuals seeking treatment for substance use. Each group receives $10,000 to further their efforts.
“Improving the health of our communities is at the very heart of Mass General Brigham’s mission,” said Anne Klibanski, MD, president and CEO at Mass General Brigham. “Through the Kraft Center and this Kraft Prize, we are proud to support the innovative work that is being done by companies like ThriveLink to make high-quality care more accessible and effective for all.”
“The Kraft Prize is an opportunity for us to spotlight other innovators that are working creatively and effectively to tackle some of the most pressing issues impacting community health,” said Elsie Taveras, Chief Community Health and Health Equity Officer at Mass General Brigham and Executive Director of the Kraft Center for Community Health. “In this first year, we had an incredibly impressive group of applicants from across the country. Our selections of ThriveLink, Mae and Sober Sidekick show just how impactful these organizations are and can be. It is our honor to recognize their efforts.”
“These companies and their leaders are setting the example for how innovation and technology can be leveraged to make transformative changes in community health,” said Robert Kraft, chairman and CEO of the Kraft Group. “We hope that the Prize can further help motivate them and enhance the outstanding work they are doing for individuals and families across the country.”
In addition to the $100,000 winning prize, ThriveLink will have an opportunity for its Founder and CEO, Kwamane Liddell, to present on two panels focused on community health and innovation at the Mass General Brigham World Medical Innovation Forum (WMIF) taking place in Boston on September 15-16. The WMIF brings together more than 2,000 global leaders from across industries to collaborate on transformative health solutions. Mae and Sober Sidekick will also have representation on a panel at the WMIF.
The Kraft Center for Community Health will also provide tailored and unique support to ThriveLink team members, including access to Mass General Brigham’s extensive Innovation MESH Network and MESH Core, linking them to other innovators, collaborators, and resources to enhance and further their important work.
“It’s an incredible honor and blessing to receive the inaugural Kraft Prize,” said Kwamane Liddell, founder and CEO of ThriveLink. “Every day, we serve families who often feel unseen — families we may pass in the grocery store or encounter in our health systems without realizing they are struggling with food and other basic needs. ThriveLink winning this award is a powerful reminder to those families that we see you.”
Launched in February 2025, the Kraft Prize is centered on five priority areas: cardiometabolic disease, substance use disorder, cancer, maternal health and social risk mitigation. Applicants needed to demonstrate a clear and measurable impact on community health in at least one of these priority areas and show community engagement in the development and implementation of their company, program or innovation.
"Mae is honored to be a finalist for the Kraft Prize for Excellence and Innovation in Community Health in recognition of our work to make maternal health more accessible and equitable,” said Maya Hardigan, founder and CEO of Mae. “We are deeply committed to expanding access to high-impact doula support and other critical resources, in partnership with health plans and community-based doulas, to drive better outcomes and support healthier births."
“Sober Sidekick has surpassed 1 million unique installs, scaling the greatest wave of comeback stories the world has ever seen,” said Chris Thompson, founder and CEO of Sober Sidekick. “That growth and its impact is what the Kraft Prize recognition affirms: we’re pioneering a new model for addiction care that puts community connection at its center. Traditional healthcare often treats addiction as an individual problem, but our platform proves that recovery is a collective journey. With peer support available 24/7 and where people can connect within seconds at their most vulnerable moments, we see measurable outcomes: a 48% reduction in relapse rates and thousands of dollars in healthcare savings per member.”
To learn more about the winner and finalists of the 2025 Kraft Prize, visit massgeneralbrigham.org/kraftprize.
###
About the Kraft Center for Community Health
The Kraft Center for Community Health at Mass General Brigham was established with the mission to expand access to high-quality, cost-effective healthcare for medically underserved patients and communities. Founded in 2011 through a generous donation by Robert Kraft, the Center aims to catalyze innovative solutions to real world community health problems, execute solutions locally, and make them scalable and ready to spread nationally to improve health outcomes for disadvantaged populations nationally. The Kraft Center is an innovation leader across the Mass General Brigham system, specializing in programmatic design and implementation to improve community health. For more information, please visit kraftcommunityhealth.org.
About Mass General Brigham
Mass General Brigham is an integrated academic health care system, uniting great minds to solve the hardest problems in medicine for our communities and the world. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a nonprofit organization committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations with several Harvard Medical School teaching hospitals. For more information, please visit massgeneralbrigham.org.
END
Researchers at Hiroshima University have developed a realistic, highly sensitive method to detect the Unruh effect—a long-predicted phenomenon at the crossroads of relativity and quantum theory. Their novel approach opens new possibilities for exploring fundamental physics and for developing advanced technologies.
The work is published in Physical Review Letters on July 23, 2025.
The Fulling-Davies-Unruh effect, or simply the Unruh effect, is a striking theoretical prediction at the profound intersection of Albert Einstein's Theory of Relativity and Quantum Theory. “In quantum theory, even the vacuum seethes with tiny energy fluctuations, ...
Americans are more knowledgeable this year in answering basic civics questions, according to the Annenberg Constitution Day Civics Survey, conducted annually by the Annenberg Public Policy Center (APPC) of the University of Pennsylvania.
More than two-thirds of U.S. adults (70%) are able to name all three branches of government – the executive, judicial, and legislative – significantly more than a year ago (65%). When asked which rights the First Amendment guarantees, 79% can name “freedom of speech,” an increase over ...
Ginseng has long been used in traditional medicine to replenish Qi and address deficiency syndromes, often manifesting as fatigue and immune compromise. Modern research is now elucidating the mechanisms behind these effects, focusing on ginseng’s immunomodulatory properties, ability to improve quality of life, and potential role in cancer therapy. This review aims to consolidate recent findings on these aspects, highlighting both the promises and limitations of ginseng as a scientifically supported therapeutic agent.
Immunomodulatory Effects of Ginseng
Ginseng’s immunomodulatory properties are primarily attributed to its active compounds, ginsenosides ...
Meningiomas are the most common primary brain tumors, accounting for nearly one-third of all central nervous system (CNS) tumors. While most are benign and manageable, 20–30% progress to high-grade forms that behave aggressively, recur frequently, and resist standard treatments. Recurrence remains a major clinical challenge, as these tumors often return stronger, leaving patients with limited therapeutic options. Despite advances in understanding their genetic and molecular profiles, how meningiomas evolve from primary to recurrent states has remained ...
People are exposed to millions of fungal spores every day, even potentially harmful ones like those from Aspergillus fumigatus. For most individuals, this constant exposure is harmless, as the immune system efficiently clears the spores without causing illness. However, for a growing number of people with weakened immune systems due to cancer, organ transplants, or chronic diseases, Aspergillus spores can lead to life-threatening infections known as aspergillosis. Thus, understanding the specific immune mechanisms that fight fungal infections is essential for developing therapies ...
In today’s world, people are increasingly prioritizing their health and well-being, with daily exercises and calorie-tracking apps becoming the new norm. People are therefore interested in incorporating highly nutritious food items such as fruits and vegetables into their diet plans. However, these foods—owing to contamination as well as due to certain cooking methods such as heating, smoking, grilling, roasting, and frying—may contain polycyclic aromatic hydrocarbons (PAHs) (hydrophobic organic compounds comprising ...
ROCHESTER, Minnesota — A new genetic test developed at Mayo Clinic is redefining how clinicians diagnose and manage hereditary pancreatitis. Pancreatitis, inflammation of the pancreas, is a complex condition that can lead to chronic pain, repeated hospitalizations and serious complications including diabetes, kidney failure and pancreatic cancer.
The new hereditary pancreatitis gene panel available through Mayo Clinic Laboratories (Mayo ID: PANGP) resulted from collaboration ...
Mentavi Health announced that its landmark, real-world validation study of the Mentavi Diagnostic Evaluation has been published in the peer-reviewed Journal of Clinical Psychiatry (JCP), a widely read and respected journal. The open-access article demonstrates that Mentavi’s asynchronous, online evaluation is as accurate as a traditional face-to-face clinical interview in the diagnosis of attention-deficit / hyperactivity disorder (ADHD) in adults and provides the first peer-reviewed evidence base for a fully digital ...
A zigzag stitch enables fabric to stretch until the thread is straight. University of Tartu researchers report in Advanced Materials that thread packing can encode fabric stretchability, leading the way to tailoring wearables at industrial scale.
As every body is unique, achieving a perfect dynamic fit of garments has to date relied on artisanal tailoring that cannot scale. Machine embroidery can place load-bearing thread in arbitrary patterns, but has been applied almost exclusively for visual appeal, such as logos and decorations. Embroidery machines ...
Multisystemic smooth muscle dysfunction syndrome (MSMDS) is a rare condition associated with stroke, aortic dissection (tearing) and death in childhood. Currently, there is no effective treatment or cure for MSMDS. A single error in the genetic code of the ACTA2 gene, which encodes the smooth muscle actin protein, is the most common cause of MSMDS. To directly target this mutation, researchers from Mass General Brigham engineered a bespoke CRISPR-Cas9 gene-editing enzyme to develop a potential therapy for ...
